GEN Exclusives

More »

GEN News Highlights

More »
Apr 4, 2007

Pfizer and pSivida Ink $165M Deal

  • Pfizer gained access to pSivida's controlled drug delivery technologies, including the Medidur™ technology in ophthalmic applications.

    Under this exclusive, worldwide CRADA, pSivida stands to earn $155 million in development and sales related milestones. Pfizer will fund the total cost of the joint research program aimed at developing products using pSivida’s technologies.

    Pfizer also reports that it invested $5 million in pSivida and plans to contribute an additional $5 million subject to certain conditions.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?